Introduction of Core Outcome Set-STAndards for Reporting (COS-STAR)_Chinese Journal of Evidence-Based Medicine

Authors：

ZHANG Mingyan , YANG Fengwen , LI Yue , ZHENG Wenke ,  ZHANG Junhua

Centre of Evidence-Based Medicine, Tianjin University of TCM, Tianjin, 300193, P.R.China;

Corresponding author：

ZHANG Junhua, Email: zjhtcm@foxmail.com

Keywords：

Core outcome set; Standards for reporting; Core Outcome Set-STAndards for Reporting; Introduction; Application

DOI：

10.7507/1672-2531.201703121

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

The Core Outcome Set-STAndards for Reporting (COS-STAR) is a latest guide tool made by Core Outcome Measures in Effectiveness Trials (COMET) group. It can enhance the transparency and completeness of Core Outcome Set (COS) report. This paper introduces the generation process, report items and application of COS-STAR to provide reference for domestic similar researches.

Citation： ZHANG Mingyan, YANG Fengwen, LI Yue, ZHENG Wenke, ZHANG Junhua. Introduction of Core Outcome Set-STAndards for Reporting (COS-STAR). Chinese Journal of Evidence-Based Medicine, 2017, 17(7): 857-861. doi: 10.7507/1672-2531.201703121 Copy

1.	Thornley B, Adams C. Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ, 1998, 317(7167): 1181-1184.
2.	Adams CE, Awad G, Rathbone J, et al. Chlorpromazine versus placebo for schizophrenia. Cochrane Database Syst Rev, 2007, 18(2): CD000284.
3.	Kirkham JJ, Gorst S, Altman DG, et al. COS-STAR: a reporting guideline for studies developing core outcome sets (protocol). Trials, 2015, 16: 373.
4.	Williamson PR, Altman DG, Blazeby JM, et al. Driving up the quality and relevance of research through the use of agreed core outcomes. J Health Serv Res Policy, 2012, 17(1): 1-2.
5.	Gargon E, Gurung B, Medley N, et al. Choosing important health outcomes for comparative effectiveness research: a systematic review. PLoS One, 2014, 9(6): e99111.
6.	Gorst SL, Gargon E, Clarke M, et al. Choosing important health outcomes for comparative effectiveness research: an updated review and user survey. PLoS One, 2016, 11(1): e0146444.
7.	Williamson PR, Altman DG, Blazeby JM, et al. Developing core outcome sets for clinical trials: issues to consider. Trials, 2012, 13: 132.
8.	Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet, 2009, 374(9683): 86-89.
9.	Kirkham JJ, Gorst S, Altman DG, et al. Core Outcome Set-STAndards for reporting: the COS-STAR statement. PLoS Med, 2016, 13(10): e1002148.
10.	Moher D, Schulz KF, Simera I, et al. Guidance for developers of health research reporting guidelines. PloS Med, 2010, 7(2): e1000217.
11.	Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med, 2010, 7(3): e1000251.

1. Thornley B, Adams C. Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ, 1998, 317(7167): 1181-1184.
2. Adams CE, Awad G, Rathbone J, et al. Chlorpromazine versus placebo for schizophrenia. Cochrane Database Syst Rev, 2007, 18(2): CD000284.
3. Kirkham JJ, Gorst S, Altman DG, et al. COS-STAR: a reporting guideline for studies developing core outcome sets (protocol). Trials, 2015, 16: 373.
4. Williamson PR, Altman DG, Blazeby JM, et al. Driving up the quality and relevance of research through the use of agreed core outcomes. J Health Serv Res Policy, 2012, 17(1): 1-2.
5. Gargon E, Gurung B, Medley N, et al. Choosing important health outcomes for comparative effectiveness research: a systematic review. PLoS One, 2014, 9(6): e99111.
6. Gorst SL, Gargon E, Clarke M, et al. Choosing important health outcomes for comparative effectiveness research: an updated review and user survey. PLoS One, 2016, 11(1): e0146444.
7. Williamson PR, Altman DG, Blazeby JM, et al. Developing core outcome sets for clinical trials: issues to consider. Trials, 2012, 13: 132.
8. Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet, 2009, 374(9683): 86-89.
9. Kirkham JJ, Gorst S, Altman DG, et al. Core Outcome Set-STAndards for reporting: the COS-STAR statement. PLoS Med, 2016, 13(10): e1002148.
10. Moher D, Schulz KF, Simera I, et al. Guidance for developers of health research reporting guidelines. PloS Med, 2010, 7(2): e1000217.
11. Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med, 2010, 7(3): e1000251.

Previous Article
Application of RevMan 5.3 software for data transformation in etiological and prognostic meta-analysis WANGChaoyang, WENG Hong, LI Binghui, REN Xuequn, ZENG Xiantao
Next Article
Accessibility of high-cost anti-cancer medicines in China ZHOUYanping, WANG Haigang, HU Qinghe, ZHOU Runshi, CHENG Lishan, KANG Fenheng, SUN Jing

Chinese Journal of Evidence-Based Medicine

Introduction of Core Outcome Set-STAndards for Reporting (COS-STAR)

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content